Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by mattw1100on Jan 18, 2019 11:15am

115 Views

Post# 29251239

RE:RE:RE:RE:SPCEO1 Trogarzo Bloomberg Data Trends?

I would take the number with a grain of salt here guys, it's directional and in reality it could be 15 patients, who knows. I just want to see upward momentum of bloomberg # vials per week trend. Sounds as if it's pretty strong to start the year.

Bullboard Posts

98% energy efficiency: How Acceleware's EM Technology is transforming heat solutions